Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/ritonavir monotherapy for HIV in CSF
NCT01116817Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Aug 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Ultrasensitive HIV-1 RNA in Cerebrospinal Fluid at 0 weeks. Started Aug 2010; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01116817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116817.